Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03ABAntidotes
- Chemical substanceV03AB24Digitalis antitoxin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
New Zealand
PHARMAC (NZ funding schedule) · 2 registrations
United States
FDA · 2 registrations
At a glance
- ATC code
- V03AB24
- ATC group
- Various
- Registers
- 3
- Registrations
- 6
- With their own page
- 4
- Companies
- 4
All medicines with Digitalis antitoxin
Human medicines from every register that match Digitalis antitoxin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Digifab | United States | 40MG | For Injection | Marketed | Salvagenix Inc. |
| Digifab | Canada | 40 MG / VIAL | Powder For Solution | Marketed | BTG International INC |
| Any | New Zealand | Inj 38 mg vial | Funded | ||
| Any | New Zealand | Inj 40 mg vial | Funded | ||
| Digitoxin | Taiwan | （粉） | Cancelled | 東信化學藥品有限公司 | |
| Digibind | United States | 38MG | For Injection | Withdrawn | Wellcome Foundation Limited Wellcome Research Laboratories |
| Digibind | Canada | 38 MG / VIAL | Powder For Solution | Cancelled | Glaxosmithkline INC |